Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alyssa Obermayer

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Current Protein & Peptide Science|November 23, 2021
Solving Protein Structure with AI: Viva AlphaFold and Co.!Alyssa Obermayer, Vladimir N Uversky
Biology|February 25, 2022
DRPPM-EASY: A Web-Based Framework for Integrative Analysis of Multi-Omics Cancer DatasetsAlyssa Obermayer, Li Dong, Qianqian Hu, et al.
Research Square|March 30, 2023
DRPPM-PATH-SURVEIOR: Plug-and-Play Survival Analysis of Pathway-level Signatures and Immune ComponentsAlyssa Obermayer, Darwin Chang, Gabrielle Nobles, et al.
Journal for Immunotherapy of Cancer|February 26, 2025
Effector T cells under hypoxia have an altered transcriptome similar to tumor-stressed T cells found in non-responsive melanoma patientsMate Z Nagy, Lourdes B Plaza-Rojas, Justin C Boucher, et al.
Leukemia|November 26, 2024
Comprehensive genomic analysis reveals molecular heterogeneity in pediatric ALK-positive anaplastic large cell lymphomaTimothy I Shaw, Stanley Pounds, Xueyuan Cao, et al.
Research Square|April 8, 2024
Comprehensive genomic analysis reveals molecular heterogeneity in pediatric ALK-positive anaplastic large cell lymphomaTimothy I Shaw, Stanley Pounds, Xueyuan Cao, et al.
Blood Advances|February 12, 2025
Mitigating T-cell mitochondrial dysfunction in CLL to augment CAR T-cell therapy: evaluation in an immunocompetent modelWael Gamal, Nienke B Goedhart, Helga Simon-Molas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 20, 2025
Integrative Immune Signature of Complementary Circulating and Tumoral Biomarkers Maximizes the Predictive Power of Adjuvant Immunotherapeutic Benefits in High-Risk MelanomaAhmad A Tarhini, Alyssa Obermayer, Sandra J Lee, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 2, 2024
Pathogenic Roles for RNASET2 in Clear Cell Renal Cell CarcinomaTaylor Peak, Yijun Tian, Aman Patel, et al.
Research Square|August 13, 2025
ShinyEvents: harmonizing longitudinal data for real world survival estimationAlyssa Obermayer, Joshua Davis, Divya Priyanka Talada, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Current Protein & Peptide Science|November 23, 2021
Solving Protein Structure with AI: Viva AlphaFold and Co.!Alyssa Obermayer, Vladimir N Uversky
Biology|February 25, 2022
DRPPM-EASY: A Web-Based Framework for Integrative Analysis of Multi-Omics Cancer DatasetsAlyssa Obermayer, Li Dong, Qianqian Hu, et al.
Research Square|March 30, 2023
DRPPM-PATH-SURVEIOR: Plug-and-Play Survival Analysis of Pathway-level Signatures and Immune ComponentsAlyssa Obermayer, Darwin Chang, Gabrielle Nobles, et al.
Journal for Immunotherapy of Cancer|February 26, 2025
Effector T cells under hypoxia have an altered transcriptome similar to tumor-stressed T cells found in non-responsive melanoma patientsMate Z Nagy, Lourdes B Plaza-Rojas, Justin C Boucher, et al.
Leukemia|November 26, 2024
Comprehensive genomic analysis reveals molecular heterogeneity in pediatric ALK-positive anaplastic large cell lymphomaTimothy I Shaw, Stanley Pounds, Xueyuan Cao, et al.
Research Square|April 8, 2024
Comprehensive genomic analysis reveals molecular heterogeneity in pediatric ALK-positive anaplastic large cell lymphomaTimothy I Shaw, Stanley Pounds, Xueyuan Cao, et al.
Blood Advances|February 12, 2025
Mitigating T-cell mitochondrial dysfunction in CLL to augment CAR T-cell therapy: evaluation in an immunocompetent modelWael Gamal, Nienke B Goedhart, Helga Simon-Molas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 20, 2025
Integrative Immune Signature of Complementary Circulating and Tumoral Biomarkers Maximizes the Predictive Power of Adjuvant Immunotherapeutic Benefits in High-Risk MelanomaAhmad A Tarhini, Alyssa Obermayer, Sandra J Lee, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 2, 2024
Pathogenic Roles for RNASET2 in Clear Cell Renal Cell CarcinomaTaylor Peak, Yijun Tian, Aman Patel, et al.
Research Square|August 13, 2025
ShinyEvents: harmonizing longitudinal data for real world survival estimationAlyssa Obermayer, Joshua Davis, Divya Priyanka Talada, et al.
Pageof 2